Alpha Teknova Inc

NASDAQ:TKNO USA Drug Manufacturers - Specialty & Generic
Market Cap
$154.16 Million
Market Cap Rank
#23621 Global
#8238 in USA
Share Price
$2.88
Change (1 day)
-4.32%
52-Week Range
$1.99 - $7.06
All Time High
$27.98
About

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample m… Read more

Alpha Teknova Inc (TKNO) - Total Assets

Latest total assets as of September 2025: $107.62 Million USD

Based on the latest financial reports, Alpha Teknova Inc (TKNO) holds total assets worth $107.62 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Alpha Teknova Inc - Total Assets Trend (2019–2024)

This chart illustrates how Alpha Teknova Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Alpha Teknova Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Alpha Teknova Inc's total assets of $107.62 Million consist of 36.0% current assets and 64.0% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 3.1%
Accounts Receivable $4.31 Million 3.6%
Inventory $6.80 Million 5.7%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $13.09 Million 11.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2019–2024)

This chart illustrates how Alpha Teknova Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Alpha Teknova Inc's current assets represent 36.0% of total assets in 2024, an increase from 26.4% in 2019.
  • Cash Position: Cash and equivalents constituted 3.1% of total assets in 2024, down from 7.1% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 63.0% in 2019.
  • Asset Diversification: The largest asset category is intangible assets at 11.0% of total assets.

Alpha Teknova Inc Competitors by Total Assets

Key competitors of Alpha Teknova Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Alpha Teknova Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.22 - 0.50

Lower asset utilization - Alpha Teknova Inc generates 0.32x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -31.18% - 5.67%

Negative ROA - Alpha Teknova Inc is currently not profitable relative to its asset base.

Alpha Teknova Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.27 4.73 4.14
Quick Ratio 4.27 3.94 3.24
Cash Ratio 0.00 0.00 0.00
Working Capital $29.63 Million $ 36.21 Million $ 12.45 Million

Alpha Teknova Inc - Advanced Valuation Insights

This section examines the relationship between Alpha Teknova Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.49
Latest Market Cap to Assets Ratio 0.25
Asset Growth Rate (YoY) -7.6%
Total Assets $118.77 Million
Market Capitalization $29.86 Million USD

Valuation Analysis

Below Book Valuation: The market values Alpha Teknova Inc's assets below their book value (0.25 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Alpha Teknova Inc's assets decreased by 7.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Alpha Teknova Inc (2019–2024)

The table below shows the annual total assets of Alpha Teknova Inc from 2019 to 2024.

Year Total Assets Change
2024-12-31 $118.77 Million -7.64%
2023-12-31 $128.59 Million -15.55%
2022-12-31 $152.26 Million -8.56%
2021-12-31 $166.51 Million +164.68%
2020-12-31 $62.91 Million +7.52%
2019-12-31 $58.51 Million --